{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:53:05Z","timestamp":1780066385212,"version":"3.54.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7,15]]},"DOI":"10.1093\/infdis\/jiu085","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T03:09:11Z","timestamp":1391828951000},"page":"200-208","source":"Crossref","is-referenced-by-count":54,"title":["Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody"],"prefix":"10.1093","volume":"210","author":[{"given":"Craig J.","family":"van Dolleweerd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey Y-H.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley C.","family":"Banyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Both","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester C. T.","family":"Lotter-Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsepo","family":"Tsekoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baby","family":"Phahladira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonderful","family":"Shumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ereck","family":"Chakauya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude T.","family":"Sabeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Fooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel K.","family":"Chikwamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian K-C.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,7]]},"reference":[{"key":"key\n\t\t\t\t20170425182617_JIU085C1","article-title":"WHO Fact Sheet no. 99","author":"World Health Organization"},{"key":"key\n\t\t\t\t20170425182617_JIU085C2","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1371\/journal.pntd.0000339","article-title":"Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies","volume":"2","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170425182617_JIU085C3","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1016\/j.vaccine.2009.06.030","article-title":"The fight against rabies in Africa: from recognition to action","volume":"27","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170425182617_JIU085C4","first-page":"211","article-title":"Rabies remains a \u2018neglected disease","volume":"10","year":"2005","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170425182617_JIU085C5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","article-title":"Passive immunity in the prevention of rabies","volume":"12","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170425182617_JIU085C6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170425182617_JIU085C7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1474-4422(02)00041-8","article-title":"Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges","volume":"1","year":"2002","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425182617_JIU085C8","doi-asserted-by":"crossref","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","article-title":"Novel vaccines to human rabies","volume":"3","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170425182617_JIU085C9","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Clinical practice: prophylaxis against rabies","volume":"351","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425182617_JIU085C10","first-page":"S47","article-title":"Rabies and African bat lyssavirus encephalitis and its prevention","volume":"36","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170425182617_JIU085C11","first-page":"238","article-title":"Equine rabies immunoglobulin: a study on its clinical safety","volume":"103","year":"2005","journal-title":"J Indian Med Assoc"},{"key":"key\n\t\t\t\t20170425182617_JIU085C12","article-title":"WHO consultation on a rabies monoclonal antibody cocktail for rabies post exposure treatment","author":"World Health Organization","year":"2002"},{"key":"key\n\t\t\t\t20170425182617_JIU085C13","article-title":"WHO expert consultation on rabies (1st report). WHO technical report series 931","author":"World Health Organization","year":"2005"},{"key":"key\n\t\t\t\t20170425182617_JIU085C14","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","year":"2005","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170425182617_JIU085C15","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170425182617_JIU085C16","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.vaccine.2013.01.025","article-title":"Monoclonal antibodies for prophylactic and therapeutic use against viral infections","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170425182617_JIU085C17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","article-title":"Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin","volume":"193","year":"2006","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425182617_JIU085C18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies","volume":"188","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425182617_JIU085C19","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/JVI.64.6.3087-3090.1990","article-title":"Biological characterization of human monoclonal antibodies to rabies virus","volume":"64","year":"1990","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170425182617_JIU085C20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/hyb.1991.10.547","article-title":"A rabies-specific human monoclonal antibody that protects mice against lethal rabies","volume":"10","year":"1991","journal-title":"Hybridoma"},{"key":"key\n\t\t\t\t20170425182617_JIU085C21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(99)00223-9","article-title":"The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure","volume":"235","year":"2000","journal-title":"J Immunol Methods"},{"key":"key\n\t\t\t\t20170425182617_JIU085C22","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/S0264-410X(01)00135-9","article-title":"Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis","volume":"19","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170425182617_JIU085C23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/hv.3.5.4386","article-title":"Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies","volume":"3","year":"2007","journal-title":"Hum Vaccin"},{"key":"key\n\t\t\t\t20170425182617_JIU085C24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4161\/hv.7.3.14456","article-title":"Molecular pharming: future targets and aspirations","volume":"7","year":"2011","journal-title":"Hum Vaccin"},{"key":"key\n\t\t\t\t20170425182617_JIU085C25","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1073\/pnas.0832472100","article-title":"Function and glycosylation of plant-derived antiviral monoclonal antibody","volume":"100","year":"2003","journal-title":"P Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425182617_JIU085C26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","article-title":"Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies","volume":"84","year":"1989","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170425182617_JIU085C27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","article-title":"A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis","volume":"58","year":"2007","journal-title":"Ann Rev Med"},{"key":"key\n\t\t\t\t20170425182617_JIU085C28","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170425182617_JIU085C29","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","article-title":"Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates","volume":"25","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170425182617_JIU085C30","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1016\/j.vaccine.2012.09.027","article-title":"Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170425182617_JIU085C31","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1096\/fj.12-219964","article-title":"Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans","volume":"27","year":"2013","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170425182617_JIU085C32","first-page":"947","article-title":"Antigenic determinants of rabies virus as demonstrated by monoclonal antibody","volume-title":"The Replication of Negative Strand Viruses: Developments in Cell Biology","year":"1981"},{"key":"key\n\t\t\t\t20170425182617_JIU085C33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3181\/00379727-98-23997","article-title":"Growth of rabies virus in non-nervous tissue culture","volume":"98","year":"1958","journal-title":"Proc Soc Exp Biol Med"},{"key":"key\n\t\t\t\t20170425182617_JIU085C34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1472-6750-11-128","article-title":"Antibody degradation in tobacco plants: a predominantly apoplastic process","volume":"11","year":"2011","journal-title":"BMC biotechnology"},{"key":"key\n\t\t\t\t20170425182617_JIU085C35","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/pmic.200700968","article-title":"Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides","volume":"8","year":"2008","journal-title":"Proteomics"},{"key":"key\n\t\t\t\t20170425182617_JIU085C36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","year":"1998","journal-title":"J Immunol Methods"},{"key":"key\n\t\t\t\t20170425182617_JIU085C37","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","article-title":"Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses","volume":"23","year":"2005","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170425182617_JIU085C38","first-page":"88","article-title":"The fluorescent antibody test","volume-title":"Laboratory Techniques in Rabies","year":"1996","edition":"4th ed"},{"key":"key\n\t\t\t\t20170425182617_JIU085C39","article-title":"Sequences of proteins of immunological interest","year":"1991","edition":"5th Edition ed"},{"key":"key\n\t\t\t\t20170425182617_JIU085C40","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","article-title":"Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity","volume":"75","year":"2001","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170425182617_JIU085C41","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1073\/pnas.0803636105","article-title":"Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study","volume":"105","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170425182617_JIU085C42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4161\/hv.7.3.14266","article-title":"Emerging antibody products and Nicotiana manufacturing","volume":"7","year":"2011","journal-title":"Hum Vaccines"},{"key":"key\n\t\t\t\t20170425182617_JIU085C43","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.1128\/JVI.01153-10","article-title":"Quantifying antigenic relationships among the lyssaviruses","volume":"84","year":"2010","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170425182617_JIU085C44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/glycob\/9.4.365","article-title":"N-glycosylation of a mouse IgG expressed in transgenic tobacco plants","volume":"9","year":"1999","journal-title":"Glycobiology"},{"key":"key\n\t\t\t\t20170425182617_JIU085C45","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1467-7652.2011.00638.x","article-title":"Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice","volume":"9","year":"2011","journal-title":"Plant Biotechnol J"},{"key":"key\n\t\t\t\t20170425182617_JIU085C46","doi-asserted-by":"crossref","first-page":"e68772","DOI":"10.1371\/journal.pone.0068772","article-title":"Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody","volume":"8","year":"2013","journal-title":"PloS one"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T06:12:15Z","timestamp":1597471935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiu085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,7]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,7]]},"published-print":{"date-parts":[[2014,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiu085","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,7]]}}}